Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Patent News

Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases

Author(s): Surya K. De*

Volume 31, Issue 34, 2024

Published on: 20 September, 2023

Page: [5657 - 5659] Pages: 3

DOI: 10.2174/0929867331666230726112328

Price: $65

conference banner
Abstract

This paper describes the synthesis of some heteroaryl compounds and compositions comprising an effective amount of one or more such compounds and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway, comprising administering an adequate amount of a heteroaryl compound to a patient in need thereof. These compounds are mTOR/PI3K/Akt pathway inhibitors.

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy